What Researchers Did
Researchers conducted an unblinded, open-label non-randomized trial to investigate the combined use of topical hyperbaric oxygen and low-energy laser for treating 374 patients with refractory diabetic foot ulcers and chronic venous ulcers.
What They Found
Complete ulcer closure was achieved in 78% of patients in both the diabetic foot ulcer (170 patients) and chronic venous ulcer (127 patients) groups. Treatment failure, leading to amputation in 22% of diabetic foot ulcer patients (48 patients) or non-closure in 22% of chronic venous ulcer patients (29 patients), was observed. The average length of therapy was similar (3.7 vs 4.1 months), though chronic venous ulcer patients required more treatments (40 vs 31.4).
What This Means for Canadian Patients
This study suggests that a combination of topical hyperbaric oxygen and low-energy laser could be a safe, effective, and potentially inexpensive treatment option for Canadian patients suffering from chronic diabetic foot ulcers and venous ulcers. This combined therapy may offer a new approach to improve healing rates and reduce complications for these difficult-to-treat conditions.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or participants.
Study Limitations
A key limitation of this study is its unblinded, open-label, non-randomized design, which means the findings require confirmation through more rigorous double-blind, randomized, controlled trials.